- Home
- ETON vs EVE Comparison
ETON vs EVE Comparison
Compare ETON & EVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- EVE
- Stock Information
- Founded
- ETON 2017
- EVE 2021
- Country
- ETON United States
- EVE United States
- Employees
- ETON N/A
- EVE N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- EVE Blank Checks
- Sector
- ETON Health Care
- EVE Finance
- Exchange
- ETON Nasdaq
- EVE Nasdaq
- Market Cap
- ETON 199.5M
- EVE 161.5M
- IPO Year
- ETON 2018
- EVE 2021
- Fundamental
- Price
- ETON $10.02
- EVE $11.30
- Analyst Decision
- ETON Strong Buy
- EVE
- Analyst Count
- ETON 3
- EVE 0
- Target Price
- ETON $12.00
- EVE N/A
- AVG Volume (30 Days)
- ETON 212.9K
- EVE 5.3K
- Earning Date
- ETON 11-12-2024
- EVE 01-01-0001
- Dividend Yield
- ETON N/A
- EVE N/A
- EPS Growth
- ETON N/A
- EVE 4067.26
- EPS
- ETON N/A
- EVE 0.24
- Revenue
- ETON $34,677,000.00
- EVE N/A
- Revenue This Year
- ETON $19.61
- EVE N/A
- Revenue Next Year
- ETON $82.71
- EVE N/A
- P/E Ratio
- ETON N/A
- EVE $46.28
- Revenue Growth
- ETON 5.64
- EVE N/A
- 52 Week Low
- ETON $3.03
- EVE $10.63
- 52 Week High
- ETON $11.11
- EVE $12.03
- Technical
- Relative Strength Index (RSI)
- ETON 67.30
- EVE 74.73
- Support Level
- ETON $8.76
- EVE $11.27
- Resistance Level
- ETON $11.11
- EVE $11.22
- Average True Range (ATR)
- ETON 0.66
- EVE 0.04
- MACD
- ETON 0.10
- EVE 0.01
- Stochastic Oscillator
- ETON 62.02
- EVE 100.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About EVE EVe Mobility Acquisition Corp
EVe Mobility Acquisition Corp is a blank check company.